Telehealth in Lewy Body Dementia
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT05014971
- Status
- Recruiting
Conditions
- Lewy Body Dementia With Behavioral Disturbance
- Lewy Body Disease
- Lewy Body Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- Tele-neurohub — BEHAVIORALInterdisciplinary care delivered using telemedicine (zoom) technology which includes neurologist, physical, occupational and speech therapy, social worker and dietician.
Study Details
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Key Dates
- Start date
- Feb 28, 2022
- Status verified
- Apr 2025
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 106 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Tele-neurohubThis group will receive the tele-neurohub intervention which includes telemedicine appointments with the neurologist, speech therapist, social worker, and nutritionist at baseline, 3 months and 6 months, and PT and OT every 2 weeks for maintenance neuro-rehabilitation.
- Active Comparator: Usual care groupReceive usual care but will have study visit assessments at baseline and 6 months.
Primary Outcome Measure
Number of completed tele-health visits [ Time Frame: 6 months ]
Central Contacts
- Bhavana Patel, DO352-733-2419
- Noheli Bedenfield, MHA352-733-2419
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Florida | Gainesville | Florida | 32610 | Bhavana Patel, DO (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Gainesville, FL
By research site
Related Studies
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Longitudinal Imaging Biomarkers of Disease Progression in DLBPHASE4 · Enrolling By Invitation · Kejal Kantarci · Jacksonville, Florida
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)PHASE2 · Not Yet Recruiting · Eli Lilly and Company · Chandler, Arizona
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona